A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research

Spine J. 2012 Oct;12(10):877-80. doi: 10.1016/j.spinee.2012.11.002.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Bone Morphogenetic Protein 2 / adverse effects*
  • Clinical Trials as Topic
  • Guidelines as Topic
  • Humans
  • Off-Label Use
  • Postoperative Complications / etiology*
  • Recombinant Proteins / adverse effects
  • Spinal Fusion / adverse effects*
  • Transforming Growth Factor beta / adverse effects*

Substances

  • Bone Morphogenetic Protein 2
  • Recombinant Proteins
  • Transforming Growth Factor beta
  • recombinant human bone morphogenetic protein-2